Search research articles
Contact Us
Filters
Showing results (151-160 of 179) with videos related to
Page
of 18
Sort By:
American Journal of Cancer Research
|
September 15, 2025
Outpatient axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma: ZUMA-24 primary analysis
Lori A Leslie, John H Baird, Ian W Flinn, et al.
British Journal of Haematology
|
September 9, 2021
The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma
Forat Lutfi, Noa G Holtzman, Ankit J Kansagra, et al.
Haematologica
|
October 16, 2025
CNS infiltration by zamtocabtagene autoleucel tandem CD20/CD19 CAR T cells leading to complete remission in a patient with primary CNS lymphoma
Nancy M Hardy, Jean A Yared, Tim Luetkens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2009
Rapid immune recovery and graft-versus-host disease-like engraftment syndrome following adoptive transfer of Costimulated autologous T cells
Aaron P Rapoport, Edward A Stadtmauer, Nicole Aqui, et al.
Transplantation Proceedings
|
January 12, 2023
Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center Experience
Hanan Alkhaldi, Olga Goloubeva, Aaron P Rapoport, et al.
Blood
|
May 10, 2022
Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell-depleted lymphoma after CART therapy
Djordje Atanackovic, Tim Luetkens, Destiny Omili, et al.
Haematologica
|
September 7, 2023
Immune-mediated facial nerve paralysis in a myeloma patient post B-cell maturation antigen-targeted chimeric antigen receptor T cells
Yamini K Kathari, Haroon Ahmad, Michael E Kallen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2014
Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells
Aaron P Rapoport, Nicole A Aqui, Edward A Stadtmauer, et al.
Blood
|
October 30, 2010
Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma
Aaron P Rapoport, Nicole A Aqui, Edward A Stadtmauer, et al.
Bone Marrow Transplantation
|
February 10, 2004
Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma
G L Phillips, B R Meisenberg, D E Reece, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 179) with videos related to
Sort By:
Page
of 18
American Journal of Cancer Research
|
September 15, 2025
Outpatient axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma: ZUMA-24 primary analysis
Lori A Leslie, John H Baird, Ian W Flinn, et al.
British Journal of Haematology
|
September 9, 2021
The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma
Forat Lutfi, Noa G Holtzman, Ankit J Kansagra, et al.
Haematologica
|
October 16, 2025
CNS infiltration by zamtocabtagene autoleucel tandem CD20/CD19 CAR T cells leading to complete remission in a patient with primary CNS lymphoma
Nancy M Hardy, Jean A Yared, Tim Luetkens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2009
Rapid immune recovery and graft-versus-host disease-like engraftment syndrome following adoptive transfer of Costimulated autologous T cells
Aaron P Rapoport, Edward A Stadtmauer, Nicole Aqui, et al.
Transplantation Proceedings
|
January 12, 2023
Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center Experience
Hanan Alkhaldi, Olga Goloubeva, Aaron P Rapoport, et al.
Blood
|
May 10, 2022
Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell-depleted lymphoma after CART therapy
Djordje Atanackovic, Tim Luetkens, Destiny Omili, et al.
Haematologica
|
September 7, 2023
Immune-mediated facial nerve paralysis in a myeloma patient post B-cell maturation antigen-targeted chimeric antigen receptor T cells
Yamini K Kathari, Haroon Ahmad, Michael E Kallen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2014
Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells
Aaron P Rapoport, Nicole A Aqui, Edward A Stadtmauer, et al.
Blood
|
October 30, 2010
Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma
Aaron P Rapoport, Nicole A Aqui, Edward A Stadtmauer, et al.
Bone Marrow Transplantation
|
February 10, 2004
Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma
G L Phillips, B R Meisenberg, D E Reece, et al.
Page
of 18